Mastering Equity and Stock Trading, Cryptocurrency Investment, Digital Assets and Global Forex Market Analysis: The Ultimate Masterclass at Tredu
Gain access to expert-led courses, live market analysis, and educational webinars that turn complex concepts into actionable strategies.Learn how to trade smarter and join our community of successful traders, building sustained financial growth.
Maintain market dominance with real-time updates and expert analysis. Our educators provide focused coverage across stock trading, forex markets, and crypto investing. We translate the latest financial news into practical knowledge, empowering you to trade smarter and achieve superior execution.
XM has launched its biggest trading promotion to date, offering traders the opportunity to earn up to $52,500 in deposit bonuses over a six-week period by meeting weekly trading targets.
Proprietary Trading Strategies and Quantitative Analysis
Sharpen your execution skills and gain a decisive edge with in-depth insights delivered by our top trading educators. Explore proven trading strategies, anticipate current market trends, and leverage expert analysis specifically designed to support your trading education and accelerate your path to sustained market success.
Newmont Corporation (NYSE:NEM) Receives New Price Target from Stifel Nicolaus
Stifel Nicolaus sets a new price target for Newmont Corporation (NYSE:NEM) at $175, suggesting a potential increase of approximately 45.36%.
The stock has shown a bullish trend by crossing above its 20-day moving average, indicating a short-term momentum gain.
Despite positive technical indicators, Newmont is rated as a Zacks Rank #3 (Hold), advising investors to maintain caution.
Newmont Corporation (NYSE:NEM) is a leading gold mining company with operations worldwide. It is known for its significant contributions to the mining industry and is a major player in the production of gold and copper. Newmont competes with other mining giants like Barrick Gold and AngloGold Ashanti. Recently, Stifel Nicolaus set a new price target for NEM at $175, a notable increase from its current trading price of $120.39.
The new price target from Stifel Nicolaus suggests a potential increase of approximately 45.36% for Newmont's stock. This optimistic outlook aligns with the recent technical performance of NEM. The stock has crossed above its 20-day moving average, indicating a short-term bullish trend. This technical milestone suggests that the stock is gaining momentum, as highlighted by its 6.9% increase over the past four weeks.
Despite the positive technical indicators, Newmont is currently rated as a Zacks Rank #3 (Hold). This rating suggests a neutral stance, indicating that while there is potential for upward movement, investors should remain cautious. The 20-day simple moving average is a popular tool among traders, providing insights into short-term price trends and potential trend reversals, which could impact the stock's future performance.
As of now, Newmont's stock price is $120.51, reflecting a slight decrease of $0.22 or approximately -0.18% from the previous trading session. The stock has traded between a low of $119.62 and a high of $121.23 today. Over the past year, NEM has experienced significant volatility, with a high of $134.88 and a low of $41.23, reflecting the dynamic nature of the mining industry.
Newmont's market capitalization stands at approximately $131.5 billion, underscoring its position as a major player in the mining sector. Today's trading volume for NEM is 3,066,946 shares, indicating active investor interest. As the company continues to navigate market conditions, the new price target and recent technical trends provide valuable insights for investors considering NEM as part of their portfolio.
Tredu Team | Insights
Waste Management, Inc. (NYSE: WM) Stock Update
WM's CEO, James C. Fish Jr., sold 5,706 shares at $230.87 each, retaining 220,087 shares.
Envestnet Asset Management Inc. increased its stake in WM by 16.9%, now holding 1,001,706 shares.
WM's stock price is currently $232.03, with a year-high of $242.58 and a low of $194.11.
Waste Management, Inc. (NYSE: WM) is a leading provider of comprehensive waste management services in North America. The company offers collection, transfer, recycling, and disposal services. It competes with other waste management companies like Republic Services and Waste Connections. On February 10, 2026, WM's CEO, James C. Fish Jr., sold 5,706 shares at $230.87 each, retaining 220,087 shares.
Envestnet Asset Management Inc. has shown confidence in WM by increasing its stake by 16.9% in the third quarter. They acquired an additional 144,860 shares, totaling 1,001,706 shares, which is about 0.25% of WM. This investment is valued at $221.2 million, indicating strong institutional interest in the company.
Other investors are also increasing their holdings in WM. Peregrine Asset Advisers Inc. boosted its holdings by 372.5% to 5,046 shares, valued at $1.1 million. Telos Capital Management Inc. increased its position by 10.1%. These moves suggest a positive outlook on WM's future performance.
WM's stock is currently priced at $232.03, reflecting a $1.53 increase or 0.66% rise. The stock has fluctuated between $229 and $233.50 today. Over the past year, it reached a high of $242.58 and a low of $194.11. WM's market capitalization is approximately $93.48 billion, with a trading volume of 1,040,699 shares.
Tredu Team | Insights
Oscar Health, Inc. (NYSE:OSCR) Earnings Report Analysis
Oscar Health reported an EPS of -$1.24, missing the consensus estimate of -$0.84, and revenue of $2.81 billion, below the Zacks Consensus Estimate of $3.21 billion.
Oscar Health's financial metrics reveal a debt-to-equity ratio of 0.72 and a current ratio of 0.95, indicating moderate leverage and potential liquidity issues, respectively.
Oscar Health, Inc. (NYSE:OSCR) is a health insurance company that leverages technology to simplify healthcare. Despite its innovative approach, the company faces significant competition within the insurance industry. On February 10, 2026, Oscar Health disclosed its earnings, revealing an EPS of -$1.24, which fell short of the consensus estimate of -$0.84. The company's revenue was $2.81 billion, missing the Zacks Consensus Estimate of $3.21 billion. Despite the growth, the company struggled to meet Wall Street expectations, highlighting ongoing challenges.Oscar Health's EPS of -$1.24 marked a decline from the previous year's -$0.62 and was significantly below the consensus estimate of -$0.84. This resulted in an EPS surprise of -47.62%. The company has exceeded consensus EPS estimates three times in the past four quarters, but this quarter's results underscore the difficulties it faces.The health insurer is dealing with high utilization of medical services by its plan enrollees, impacting its financial performance. Despite these challenges, Oscar Health remains optimistic about achieving profitability within the year.
The company's price-to-sales ratio of 0.26 and enterprise value to sales ratio of 0.19 suggest a relatively low valuation compared to its sales.Oscar Health's financial metrics indicate some concerns. The debt-to-equity ratio of 0.72 suggests moderate leverage, while the current ratio of 0.95 indicates potential liquidity issues. The negative P/E ratio of -14.22 and earnings yield of -7.03% reflect ongoing losses. Despite these challenges, the company continues to focus on its growth and profitability goals.
Best Trading Strategies for Beginners (Forex & Crypto)
Tredu.com
2/4/2026
2026 Market Outlook Highlights: what to look at in 2026
Tredu.com
1/26/2026
Why Quality Trading Education Matters: How Verified Trading Educators Boost Your Financial Knowledge
Tredu.com
7/14/2025
Technology-Powered Access to Elite Trading Education
